Chiara Trentin

Learn More
OBJECTIVE To predict presence of invasive component and nodal involvement in women diagnosed preoperatively with ductal carcinoma in situ (DCIS) by vacuum-assisted breast biopsy (VABB). MATERIALS AND METHODS We retrospectively analyzed 733 patients with preoperatively diagnosed DCIS, investigating the association of clinical-radiological variables with(More)
Hereditary diffuse gastric cancer is an autosomal dominant inherited disease associated of CDH1 germline mutations (that encodes for the E-cadherin protein), and lobular breast cancer is the second most frequent type of neoplasia. Recently, novel E-cadherin constitutional alterations have been identified in pedigree clustering only for lobular breast(More)
Hereditary diffuse gastric cancer is an autosomic dominant syndrome associated with E-cadherin protein (CDH1) gene germline mutations. Clinical criteria for genetic screening were revised in 2010 by the International Gastric Cancer Linkage Consortium at the Cambridge meeting. About 40 % of families fulfilling clinical criteria for this inherited disease(More)
Among the symptoms reported by patients undergoing breast imaging, pain is one of the most common. Mastalgia is generally classified as cyclic, noncyclic, or extramammary. A rare cause of breast pain is Dercum's disease, or adiposis dolorosa, a condition characterized by multiple, often painful subcutaneous lipomas. Painful breast lipomas have not been(More)
This paper reports findings of the "Focus on Controversial Areas" Working Party of the Italian Senonetwork, which was set up to improve the care of breast cancer patients. After reviewing articles in English on the MEDLINE system on breast conserving surgery for invasive carcinoma, the Working Party presents their recommendations for identifying risk(More)
Breast lesions defined C3 at ultrasound (US)-guided fine needle aspiration cytology (FNAC) are probably benign, but exhibit atypias. We evaluate the results of US-guided vacuum assisted breast biopsy (VABB) of these lesions. Patients diagnosed C3 by US-FNAC, submitted to US-VABB and with a minimum follow-up of 36 months or surgery were enrolled. Cost(More)
S — SESSION 1 Sunday 10 October 2004, 15.00–16.00 PET, CT and tumor markers in the evaluation of postchemotherapy residuals in metastatic germ-cell tumors A C Pfannenberg, K Oechsle‡, C Kollmannsberger‡, B M Dohmen†, C Bokemeyer‡, R Bares† and C D Claussen Departments of Diagnostic Radiology, †Nuclear Medicine and ‡Oncology, University of Tuebingen,(More)
This paper aims to discuss the role and the accuracy of positron emission tomography (PET) and to evaluate computed tomography (CT) contrast enhancement in diagnosing the nature of lung nodules detected by low-dose CT, performed as screening for lung cancer. When applying strict admission criteria to the test, CT contrast enhancement is feasible in 40% of(More)
  • 1